TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 178 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $35,580 | +17.0% | 2,000 | 0.0% | 0.01% | +12.5% |
| Q1 2024 | $30,420 | -10.9% | 2,000 | 0.0% | 0.01% | -11.1% |
| Q4 2023 | $34,160 | +104.3% | 2,000 | 0.0% | 0.01% | +50.0% |
| Q3 2023 | $16,720 | -66.3% | 2,000 | 0.0% | 0.01% | -62.5% |
| Q2 2023 | $49,680 | +65.2% | 2,000 | 0.0% | 0.02% | +45.5% |
| Q1 2023 | $30,080 | +154.1% | 2,000 | 0.0% | 0.01% | +83.3% |
| Q4 2022 | $11,840 | -1.3% | 2,000 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $12,000 | +33.3% | 2,000 | 0.0% | 0.01% | +20.0% |
| Q2 2022 | $9,000 | -52.6% | 2,000 | 0.0% | 0.01% | -44.4% |
| Q1 2022 | $19,000 | -50.0% | 2,000 | 0.0% | 0.01% | -52.6% |
| Q4 2021 | $38,000 | -43.3% | 2,000 | 0.0% | 0.02% | -50.0% |
| Q3 2021 | $67,000 | -4.3% | 2,000 | 0.0% | 0.04% | -2.6% |
| Q2 2021 | $70,000 | -27.1% | 2,000 | 0.0% | 0.04% | -38.1% |
| Q1 2021 | $96,000 | -7.7% | 2,000 | 0.0% | 0.06% | -18.2% |
| Q4 2020 | $104,000 | +395.2% | 2,000 | 0.0% | 0.08% | +250.0% |
| Q1 2020 | $21,000 | – | 2,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Jetstream Capital LLC | 200,000 | $7,758,000 | 5.97% |
| Lion Point Capital, LP | 609,128 | $23,628,000 | 4.08% |
| RA Capital Management | 3,342,743 | $129,665,000 | 2.08% |
| Ghost Tree Capital, LLC | 180,000 | $6,982,000 | 1.92% |
| Nicholas Investment Partners, LP | 660,964 | $25,639,000 | 1.61% |
| ARDSLEY ADVISORY PARTNERS LP | 350,000 | $13,577,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 414,949 | $16,096,000 | 1.30% |
| Spotlight Asset Group, Inc. | 75,000 | $2,909,000 | 1.12% |
| ACT CAPITAL MANAGEMENT, LLC | 55,000 | $2,134,000 | 1.10% |
| Pier Capital, LLC | 280,486 | $10,880,000 | 1.09% |